CIK: 1758507 - Address: C/o Puma Biotechnology, Inc., 10880 Wilshire Blvd., Suite 2150, Los Angeles, CA 90024
30 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/5/24 18:49
1/3/24
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-704.490-16-11129D
7/6/23 19:12
7/3/23
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-493.310-15-9144D
1/5/23 17:40
1/3/23
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-444.180-10-9100D
12/6/22 16:30
12/2/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-14.50000111D
11/4/22 16:13
11/2/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.25000111D
10/5/22 16:40
10/3/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.34000111D
9/7/22 16:44
9/2/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.59000111D
8/4/22 21:34
8/2/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.89000112D
8/4/22 21:30
7/5/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS.a-252.630-9-8112D
7/7/22 20:19
7/5/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-152.630-6-865D
6/6/22 17:05
6/2/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS01.92000121D
5/4/22 18:46
5/3/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.34000121D
5/4/22 18:44
5/3/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.34000121D
5/4/22 18:43
5/3/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.34000121D
4/5/22 16:52
4/4/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-13.08000121D
3/4/22 17:14
3/2/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.2600059D
2/3/22 17:34
2/2/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.4800060D
1/5/22 17:04
1/3/22
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-243.190-7-1160D
12/6/21 18:37
12/2/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS02.9500067D
11/3/21 18:22
11/2/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-15.6700067D
10/6/21 17:20
10/4/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-16.2000068D
9/3/21 19:40
9/2/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-17.5100068D
8/3/21 17:52
8/2/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-17.5400068D
7/6/21 17:43
7/2/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-19.2600068D
6/4/21 16:56
6/2/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-210.7400068D
5/5/21 16:44
5/3/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-29.9100068D
4/6/21 18:02
4/5/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-29.8000069D
3/4/21 16:48
3/2/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-210.1400069D
2/4/21 17:13
2/2/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-212.2600-113D
1/6/21 18:48
1/4/21
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsNougues Maximo FCAOCFOS-2210.220-2-1413D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact